Clinical chemistry devices; classification of the biotinidase test system. Food and Drug Administration, HHS. Final rule.
The Food and Drug Administration (FDA) is classifying the biotinidase test system into class II (special controls). The special control that will apply to this device is restriction to sale, distribution, and use as a prescription device. The agency is taking this action in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976, the Safe Medical Devices Act of 1990, and the Food and Drug Administration Modernization Act of 1997. The agency is classifying these devices into class II (special controls) in order to provide a reasonable assurance of the safety and effectiveness of the devices.
D000581:Amidohydrolases / Q000032:analysis; D019963:Clinical Chemistry Tests / Q000145:classification* / Q000295:instrumentation*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000581:Amidohydrolases